«We are thrilled that Katie was selected from among more than 750 applicants,» said
Gladstone President R. Sanders «Sandy» Williams, MD. «Her innovative work has set the standards for computational biology in microbiome research.»
Other Academy members from the Gladstone community include Warner Greene, MD, PhD, Director of the Gladstone Institute of Virology and Immunology, President Emeritus Robert Mahley, MD, PhD, and
Gladstone President R. Sanders «Sandy» Williams, MD..
«Leor and Nevan pursue important scientific questions with extraordinary creativity and technological prowess,» said
Gladstone president R. Sanders «Sandy» Williams.
«Lundbeck is a truly visionary company with a well - focused strategy for building a pipeline to treat neurological disease,» said
Gladstone president R. Sanders Williams, MD. «We are enthusiastic about the potential of this important collaboration.»
Gladstone President R. Sanders «Sandy» Williams, MD congratulated Dr. Srivastava on the election, saying, «Deepak's accomplishments in cardiovascular research are exceptional.
«As both a physician and a scientist, Dr. Takahashi embodies the ideal recipient because her work brings cellular reprogramming to patients,» says
Gladstone president R. Sanders Williams, MD. «Mr. Ogawa's visionary support of translational stem cell research will help encourage and accelerate the progression of the field.»
«Katerina's research is opening new avenues to understanding mechanisms of neuroinflammation, with exciting translatable opportunities,» said
Gladstone President R. Sanders «Sandy» Williams, MD. «This new grant will accelerate her progress.
«Gladstone is uniquely qualified to take on this major research, which will fill a critical gap in the understanding of brain function and neurological disease,» said
Gladstone president Robert W. Mahley, MD, PhD.
«Gladstone lost a wonderful friend and long - time supporter,» said
Gladstone President R. Sanders «Sandy» Williams, MD. «One of Bill's many talents was to lead by example — launching great companies, giving generously to important causes, and befriending many.
Gladstone GO emerged after a meeting between graduate students and
Gladstone President R. Sanders «Sandy» Williams, MD..
«This collaboration has high potential to open new avenues towards effective therapies for neurodegenerative diseases,» said
Gladstone President R. Sanders Williams, MD. «Both organizations are committed to meeting this major unmet need.»
Other Gladstone colleagues who are also members of the AAP include
Gladstone President, R. Sanders Williams, MD; Senior Investigator and President Emeritus Robert W. Mahley, MD, PhD; Senior Investigator Lennart Mucke, MD, who directs neurological research at Gladstone, and Senior Investigator Eric Verdin involved in virology and immunology research.
«They found an excellent recipe to ensure the development of a successful therapy,» said Srivastava, who is also the incoming
Gladstone president.
«Stem cell biology has become one of the most exciting and promising areas of research, with real impact on how we treat human disease,» said
Gladstone President R. Sanders Williams, MD. «With its meetings and journals, ISSCR has developed a significant role in communicating and promoting groundbreaking advances in the field.
Not exact matches
Marty St. George, left, executive vice
president of commercial and planning for JetBlue Airways, and
Gladstone Adderley, right, general manager, cut a ribbon for the start of JetBlue service from MSP to Boston on Thursday.
In the spring of 1999, the CEGPFTP delivered its report to the
president of
Gladstone, Robert Mahley.
«This series has brought many remarkable researchers to
Gladstone over the years,» said R. Sanders «Sandy» Williams, MD,
president of
Gladstone.
«I am delighted that Dr. Greene is being acknowledged for his remarkable and continuing contributions to the scientific basis of medicine,» stated Lloyd «Holly» Smith, Jr., MD, consultant to the
president of the
Gladstone Institutes and emeritus professor of medicine and associate dean of the University of California, San Francisco.
On Wednesday, May 9, 2018, the
President's Council Symposium will offer an exclusive preview of the latest breakthroughs in
Gladstone's trailblazing scientific research.
President,
Gladstone Institutes Director, Roddenberry Stem Cell Center Senior Investigator & Director,
Gladstone Institute of Cardiovascular Disease
«Neurodegenerative diseases are some of the most pressing medical concerns today, and the prevalence of these diseases is growing as our population ages,» said Stephen B. Freedman, PhD, vice
president of corporate liaison and ventures at
Gladstone.
Mr. Moseley served as
Gladstone's Chief Financial Officer and Vice
President of Finance from 2007 - 2017.
Gladstone's
President, along with our scientific leadership — with oversight from our three Trustees — strategically guide the organization to foster and enrich innovation, talent, entrepreneurship and financial strength.
«We are delighted that Dr. Greene is being acknowledged for his work to overcome one of the world's most devastating diseases,» said R. Sanders Williams, MD,
president of
Gladstone.
Heather Kernahan,
president of Eastwick, spoke to
Gladstone's postdocs about how to build their professional brand.
Stephen B. Freedman, PhD, is Director of the
Gladstone Center for Translational Research (GCTR) and Vice
President for Corporate Liaison and Ventures at the
Gladstone Institutes.
Scott Pegg, PhD, is the Chief Information Officer and Vice
President of Research Infrastructure at the
Gladstone Institutes.
Megan Graziano McDevitt is the Vice
President of Communications at the
Gladstone Institutes.
Deepak Srivastava, MD -
President,
Gladstone Institutes Steve Finkbeiner, MD, PhD - Director, Center of Systems and Therapeutics Warner C. Greene, MD, PhD - Director, Center for HIV Cure Research Lennart Mucke, MD - Director,
Gladstone Institute of Neurological Disease Katherine S. Pollard, PhD - Director,
Gladstone Institute of Data Science and Biotechnology
Vincent E. Moseley is the Chief Investment Officer and Vice
President for Finance at the
Gladstone Institutes.
Executives in intellectual property, business development and other administration areas support the scientists» work, while two philanthropic groups — the
Gladstone Foundation and the
President's Council — offer support and guidance to accelerate our scientific mission.
He is also the
President and Treasurer of GRE, LLC — a
Gladstone - controlled real - estate investment trust (REIT) and the Secretary of the
Gladstone Foundation.
«There has been limited commercial investment in the cardiac field, despite the remarkable progress made at
Gladstone and elsewhere,» added Stephen Freedman, PhD, vice
president for corporate liaison and ventures at
Gladstone.
Today, renowned Alzheimer's researcher and founding
president of the
Gladstone Institutes, Robert Mahley, MD, PhD, has received a Seeding Drug Discovery Award from the Wellcome Trust.
«Through its basic research into the origins of neurological disease,
Gladstone has built an impressive knowledge into potential strategies and targets for treating devastating neurological diseases, such as multiple sclerosis and Alzheimer's disease,» said Peter Høngaard Andersen, Executive Vice
President of Research, H. Lundbeck A / S.
It was then that I met and began to work with
Gladstone Founding
President Robert W. Mahley, MD, PhD.
«Alzheimer's is a complex disease involving multiple factors,» said Stephen Freedman, PhD, vice
president of corporate liaison and ventures at
Gladstone.
SAN FRANCISCO, CA — May 1, 2012 — Warner C. Greene, MD, PhD, who directs virology and immunology research at the
Gladstone Institutes, has been inducted as
president of the Association of American Physicians (AAP).
«Because so many adult cells can't divide, your body can't replace cells that are lost, which causes disease,» explained Deepak Srivastava, MD,
president of the
Gladstone Institutes and senior investigator.
«Katie's successes over the past year have created a cohesive and dynamic culture that fosters interdisciplinary collaboration, forging an enhanced environment for science at
Gladstone,» shared R. Sanders «Sandy» Williams, MD,
president of
Gladstone.
«A research career in life sciences is one of the most exciting and fulfilling careers that any young person can hope for,» said R. Sanders «Sandy» Williams, MD, the physician / scientist who is
president at the
Gladstone Institutes in San Francisco.
«As shown by our analysis, new treatments depend upon a broad base of scientific knowledge plus special contributions from a few exceptional scientists,» says first author R. Sanders Williams, MD,
president of the
Gladstone Institutes.
Some of our alumni even come back — such as our former postdoc Shinya Yamanaka, MD, PhD, who is now a senior investigator at
Gladstone and former graduate student Michael L. Penn, Jr., MD, PhD, who returned to
Gladstone as vice
president for Diversity, Outreach, and Mentoring.
R. Sanders Williams, MD, known as Sandy to his colleagues and friends, has been
president of the
Gladstone Institutes since 2010.
«Most studies have centered on two key proteins associated with Alzheimer's, called amyloid - beta (Aβ) and tau,» said Dr. Mahley,
Gladstone's
president emeritus and a member of the original team of researchers that discovered apoE.
«Dick is one of my favorite people in the world,» says Robert W. Mahley, MD, PhD,
Gladstone's
president emeritus and a senior investigator.
«While we are most known for our research efforts towards finding cures to devastating diseases, we apply the same creativity to sustainability at
Gladstone,» said Sandy Williams, MD,
president of
Gladstone.
As
Gladstone's
President, Dr. Mahley oversaw the organization's establishment and growth to include three institutes.
Stephen B. Freedman, PhD, is Director of the
Gladstone Center for Translational Research and Vice
President for Corporate Liaison and Ventures at the
Gladstone Institutes.
Bob Mahley,
Gladstone's
president at the time, challenged me to establish a research program with therapeutic implications that was distinct from my postdoctoral work.